展会预告 | 博腾股份积极参与欧洲CPhI，精彩演讲即将揭幕！

一口蝴蝶酥

　　全球**业的盛会——世界制药原料展(CPhI)即将于今年10月在美丽的意大利米兰拉开帷幕。这一盛会已经成为全球**界开展商贸交流和信息共享的重要平台。预计将吸引来自超过166个国家和地区的6.2万名参与者，展商数量超过2400家，势必再次掀起**行业的热潮。
　　为了更好地与行业同仁互动，博腾股份特别在第二天(10月9日)安排了两场在展位5C17的专业演讲活动。我们的两位技术专家将为您带来前沿的技术分享和行业洞见，其详细日程如下：

　　分享主题
　　•主题一：
　　博腾斯洛文尼亚：推动CDMO行业创新，夯实全球化布局
　　•主题二：
　　制粒工程在原料药和制剂研发中的应用
　　此次分享活动将为您全面展示博腾股份在全球化步伐、技术研发和创新方面的最新成果，为您提供新视角和新思路，助力您在激烈的市场竞争中赢得先机。
　　期待与您相聚米兰，共同见证**产业的美好未来!

　　Presenter Profile

　　SVP, Head of Global Chemical Engineering and Technology Center, Porton Pharma Solutions
　　31-year experience in Pharma industry
　　Joined Porton JSTAR in 2014. previously served as the Head of Center for Pharma Crystallization, Dr. Jian Wanghas over 30 years of process R&D experience specialized in API crystallization, reaction engineering, and PAT applications. Jian earned her Ph.D. in Chemical Engineering in 1994 from University of Pittsburgh, supervised by Prof. Donna Blackmond and Prof. Irving Winder. She has authored over 20 peer-reviewed articles and holds 6 patents, 5 on API crystallization.
　　From 1994 to 2005. Jian worked at Merck, addressing bottleneck process R&D issues via reaction engineering, API crystallization, and PAT application, as well as pilot plant process execution. She consulted at Mettler Toledo AutoChem from 2005-2010 and served as VP of Crystallization Development at Crystal Pharmatech from 2011-2013. Since 2014. she established a state-of-the-art crystallization center at J-STAR Research, working on API isolation challenges across developmental stages and integrating drug formulation services with API crystallization R&D.
　　Listening to clients’ needs, building up the team’s technical capabilities, and providing the right technical solutions have been Jian’s focus for decades. Her dedication and contributions to pharma process R&D have served broad needs of diverse global clients with technical rigor, synergy and efficiency.
　　博腾股份为全球药企、生物科技公司、科研机构等提供从临床前研究到药品上市全生命周期所需的小分子药物、多肽与寡核苷酸药物、蛋白与偶联药物以及细胞与基因治疗药物等一站式服务解决方案，研发、生产、运营场地覆盖中国(重庆、上海、四川、江苏、江西、湖北)、美国、斯洛文尼亚、比利时、瑞士和丹麦等地。我们致力于以客户为中心，为客户提供卓越的全球化、端到端CDMO服务，让好药更早惠及大众。